Key Takeways

  • Essential records are generated and maintained across the full trial lifecycle: pre-trial, conduct, and closure.
  • ICH E6(R2) Section 8 remains the essential-documents framework most trials still operate under today.
  • ICH E6(R3) is being phased in with a more flexible, principle-based structure.
  • Sponsors and investigator/institution sites each maintain essential records under their own respective responsibilities.

A single missing monitoring report or an unsigned delegation log can pose questions about whether a trial was overseen the way its protocol required. It’s the reason TMF documentation gets more scrutiny than almost any other part of a study’s paper trail.

This guide covers what documents are included in a Trial Master File and how they’re organized across the trial lifecycle.

Quick Answer

Documents required for Trial Master File management include protocols, regulatory approvals, monitoring records, consent documentation, safety records, agreements, and archiving records.

ICH E6(R2) has long provided the essential-documents framework most sponsors and sites still work from today. ICH E6(R3), adopted at ICH Step 4 in 2025, is now being phased in and reframes these as “essential records” under a more principle-based approach.

What Is a Trial Master File?

A Trial Master File is the organized collection of essential records that lets anyone reviewing a trial evaluate how the study was conducted and judge the reliability of its results.

Document completeness is as important as document presence. The TMF has to provide a complete and clear account of the trial from start to finish. Even a single missing or outdated record can raise questions that go well beyond the document itself.

What Documents Should Be Included in a Trial Master File?

TMF documentation is generally organized around the points at which essential records are generated across the trial lifecycle.

The traditional three-stage structure groups these records as follows:

1. Pre-Trial Documents:

Before enrollment begins, the file starts building the record of how the trial was designed and authorized. Depending on the trial, this may include:

  • Final protocol and protocol amendments
  • Investigator’s Brochure
  • IRB/IEC approval documentation
  • Clinical trial agreements and other relevant agreements
  • Investigator qualifications and CVs
  • Financial disclosure documentation
  • Relevant regulatory authorization or submission records
  • Study-specific plans and procedures, where applicable

These records exist to answer one question before the trial even starts: was this study set up in a way that protects participants and produces reliable data?

A rigorous clinical trial site selection process helps in this regard, since investigator qualifications and site agreements are pre-trial records that tend to resurface during an audit.

2. Trial Conduct Documents:

Once the trial is underway, Trial Master File documentation starts capturing the day-to-day evidence of how the study is being conducted and managed.

Examples include:

  • Monitoring documentation
  • Informed consent documentation
  • Investigational product or device accountability records
  • Safety documentation
  • Records of protocol deviations and their resolution

This phase can generate a substantial volume of records because monitoring and operational activities continue throughout trial conduct. Safety documentation particularly connects TMF records with pharmacovigilance and drug safety monitoring activities throughout the study.

Such volumes can also make timely filing, version control, and reconciliation more challenging as the trial progresses.

3. Trial Completion/ Termination Documents:

As the trial approaches completion or termination, the focus shifts to documenting the final activities and bringing the record to an orderly close. Closure records may include:

  • Clinical study report/final study report
  • Subject identification code lists
  • Documentation of investigational product or device disposition
  • Audit documentation where applicable
  • Records related to trial close-out

ICH E6(R2) vs. ICH E6(R3): What’s Changing for TMF Documentation

Most sponsors and sites are still working from ICH E6(R2) Section 8, which lists “Essential Documents” as the minimum paperwork required for a trial. These include the study protocol, signed consent forms, IRB/IEC approvals, the Investigator’s Brochure, and similar items.

ICH E6(R3) reached ICH Step 4 in January 2025 and is intended to eventually replace E6(R2). It restructures the guideline into overarching Principles plus supporting Annexes. It also relabels “Essential Documents” as “Essential Records” that collectively allow evaluation of a trial’s conduct and results.

The shift now moves away from a fixed checklist toward a risk-proportionate approach, where what counts as “essential” varies by trial design.

The near-term takeaway for sponsor teams is to track where each trial stands in the transition, as regional adoption is still rolling out, and E6(R2) continues to apply to trials that have not yet transitioned.

Trial Master File Document Checklist

The table below brings those lifecycle stages together as a practical Trial Master File document checklist.

Trial PhaseExample DocumentsPurpose
Pre-TrialProtocol, Investigator’s Brochure, IRB/IEC approval, agreementsEstablishes that the study was authorized and designed correctly
Trial ConductMonitoring records, informed consent documentation, safety records, protocol deviation recordsProves the trial was run and overseen as designed
Trial ClosureFinal study report, subject identification code list, applicable audit documentation, closeout and archiving recordsConfirms the study concluded and was documented properly

The exact records maintained will vary according to the trial’s design, conduct, risk profile, and applicable regulatory requirements.

Electronic TMF (eTMF) vs. Paper-Based Documentation

An eTMF makes version control and audit trails, along with real-time reconciliation against a TMF index, far easier. It also timestamps exactly when a document was filed, which is useful if a report’s timeliness is ever questioned.

Most active trials today maintain their TMF electronically rather than on paper. Still, adoption of eTMFs doesn’t change the documents required for Trial Master File management. The only factors that change are how they’re indexed and made searchable.

What Documents Are Maintained at the Sponsor Level vs Site Level?

Essential records are maintained by both the sponsor and investigator/institution, with each party responsible for the records relevant to its activities and oversight.

The sponsor’s Trial Master File documentation serves as the sponsor’s repository for essential records generated and maintained through sponsor oversight and trial management. Site-level records are maintained by the investigator/institution in its own repository, commonly referred to as the Investigator Site File (ISF).

Keeping track of who maintains each record and where it is stored helps ensure that essential records remain identifiable and accessible.

What Role Does Quality Assurance Play in TMF Documentation?

A complete Trial Master File (TMF) does not maintain itself. Quality assurance in clinical trials can help identify missing signatures, outdated document versions, unresolved deviations, and other documentation issues before they affect inspection readiness.

Routine QA checks against the TMF index can also reveal missing or outdated records while there is still time to address them. That makes ongoing review much more useful than discovering documentation gaps when an inspection is already underway.

How Does TMF Documentation Support Clinical Trial Monitoring?

The documents in a Trial Master File provide an ongoing record that supports trial oversight and monitoring throughout study conduct. Once a trial is active, the quality of ongoing TMF documentation feeds directly into clinical trial monitoring. It gives monitors documented evidence of trial conduct, oversight, and compliance.

This documentation discipline is also a core thread running through the broader clinical trial management process, where TMF functions as the connective record across every stage of the study.

Is Your TMF Always Trial-Ready?

Keep essential documents organized, accessible, and ready when you need them.

Strengthen your TMF

What Are Common Documentation Gaps in a Trial Master File?

Some frequent gaps in TMF documentation themselves are often surprisingly ordinary:

  • Protocol amendments filed without the corresponding IRB or IEC approval.
  • Delegation logs missing signatures for staff who performed trial duties.
  • Monitoring visit reports filed months after the actual visit took place.
  • Informed consent forms using an outdated version after a protocol amendment.
  • Drug accountability logs with unexplained discrepancies between dispensed and returned quantities.

Consider a protocol amendment that changes the informed consent process, yet an outdated consent form stays in use. What starts as a version-control problem can raise real questions about whether the revised requirements were actually implemented. During an audit or inspection, the sponsor or site may need to explain how the issue was identified and addressed.

Final Remarks

A Trial Master File follows the story of a clinical trial through its records, from the first protocol and approval documents to monitoring records and closeout materials. Each part contributes to the record of how the study was conducted and overseen.

Minerva Research Solutions supports sponsors and clinical research teams in keeping essential documentation traceable and ready for review throughout the study lifecycle.

FAQs About TMF in Clinical Research